I am comparing three suppliers on documentation rather than on price.
I would like help reading this properly rather than being told what conclusion to reach.
I have the full report including the method section, so I can quote specifics if that helps.
What would I need in addition before this supported a decision?
The honest answer is that personal importation of a prescription-only medicine is restricted in most jurisdictions regardless of intended use.
If the amount at stake is material, this is a question for a lawyer in your jurisdiction rather than for a forum in any jurisdiction.
The authority that matters is the national medicines regulator plus the customs authority, and both usually publish their position in plain language on their own websites.
Research-use-only labelling is a commercial convention originating in laboratory supply and carries no regulatory status for an individual importer.
Nothing here is medical advice, and research-use compounds are not approved for human use in any jurisdiction.
If the stakes are material, ask a lawyer where you live rather than a forum anywhere.
edited 2 Sept 2024 by g_paskevicius — fixed an arithmetic slip in the third paragraph
HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.
Submit a sampleFounded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.
Visit GL BiochemThe short version: research-use designation is a labelling convention, not a legal exemption, and it does not travel across borders.
Some jurisdictions provide a limited personal-importation allowance for medicines, usually bounded by quantity, by a supply period and by a requirement that the substance is for the importer's own use. Others provide none.
The part that matters: onward supply — including at cost, including to friends — is treated separately and much more seriously in most regimes than importation for personal use.
National medicines regulators and customs authorities publish their positions directly, and those are the primary sources for any specific question.
Onward supply is a materially different legal act and should not be assumed to follow the same rule as personal importation.
Prior successful deliveries tell you about enforcement, not about legality.
Answering this needs the country, and even then the answer is a pointer to the relevant authority rather than a ruling.
A research-use-only label is a supplier's statement about intended use. It has no status in customs classification and does not create an exemption for the importer.
Three broad categories cover most cases: controlled or scheduled substances, prescription-only medicines, and unclassified chemicals. The rules, penalties and enforcement posture differ sharply between them.
The caveat is the whole answer: nothing here is legal advice and the rule that applies to you is local.
Research-use labelling is a seller's statement, not a legal category for you.
This is the tag where the site is least able to help and most obliged to say so plainly.
Most agents discussed on this site are prescription-only medicines where they are licensed at all, which places personal importation under medicines regulation rather than under drug-control law in most jurisdictions.
Personal-importation allowances for medicines exist in some jurisdictions with quantity and supply-period limits, and are absent in others.
Look up your own regulator and customs authority. They publish the answer directly.
"For research use only" is a statement by the seller about intended use, and it binds nobody.
Enforcement posture and legal position are not the same thing. Consignments arriving without incident establish nothing about the underlying rule.
Medicines regulation and drug-control law are distinct legal frameworks in most countries, with different scheduling and different penalties.
Absence of enforcement is not permission, and prior deliveries prove nothing about the rule.
Personal importation and onward supply are different acts under different rules.
edited 18 Oct 2024 by lane_transit — updated for the 2026 guidance change
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.